Somatic mutations in KDM6A have been found in a broad range of human cancers, including multiple myeloma, renal cell carcinoma, bladder cancer, head and neck squamous cell carcinoma, acute lymphoid leukaemia, prostate cancer, medulloblastoma, and pancreatic adenocarcinoma [9]. Here, KDM6A is linked to urinary bladder carcinoma.